TECX

Tectonic Therapeutic Inc · NASDAQ

Sector Commercial Services
Industry Miscellaneous Commercial Services
Website ectonictx.com
Employees(FY) 44
ISIN US8789721086

Performance

+5.66%

+79.2%

+98.1%

+109.07%

+92.16%

YTD

+63.33%

Profile

Tectonic Therapeutic, Inc. engages in the discovery of antibodies and other biologic drugs targeting G-protein-coupled receptors (GPCRs) to develop novel therapies for patients inadequately served by current treatments. It offers a GEODe platform to overcome the challenges encountered to date in GPCR biologic discovery campaigns and enables the advancement of novel GPCR-targeting therapies. Tectonic Therapeutic, Inc. was incorporated in 2019 and is based in Watertown, Massachusetts.

Advanced Technical Analysis

Technical Analysis of TECX 2024-10-11

The stock exhibits a strong bullish sentiment with a Moving Average Score of 90, indicating robust upward momentum, while the Technical Score of 70 further supports this positive outlook. However, the Oscillators Score of 50 suggests a neutral stance, indicating potential consolidation or indecision in the market, which could temper the overall ...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of TECX

Stock Rank

Recent News & Updates

2024-09-23 09:49
Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans(Simply Wall St.)
2024-09-19 16:01
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45(GlobeNewswire)
2024-09-19 04:01
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45(Globenewswire)
2024-08-20 16:01
Tectonic Therapeutic to Participate in September Investor Conferences(GlobeNewswire)
2024-08-20 04:01
Tectonic Therapeutic to Participate in September Investor Conferences(Globenewswire)
2024-08-14 16:01
Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights(GlobeNewswire)
2024-08-14 04:01
Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights(Globenewswire)
2024-07-30 16:01
Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45(GlobeNewswire)
2024-07-30 04:01
Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45(Globenewswire)
2024-06-20 16:01
Tectonic Therapeutic Announces Closing of Merger with AVROBIO as well as Concurrent Private Placement of $130.7 Million(Business Wire)
2024-06-19 21:47
PLTR Stock: Palantir Bags New Partnership With ARPA-H for AI/ML(Investorplace)
2024-06-19 20:26
Why Is Avrobio (AVRO) Stock Moving Today?(Investorplace)
2024-06-19 19:28
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday(Investorplace)
2024-05-14 23:27
Avrobio Insider Bought Shares Worth $971,493, According to a Recent SEC Filing(Yahoo Finance)
2024-05-12 21:53
AVRO Stock Earnings: Avrobio Beats EPS for Q1 2024(Investorplace)
2024-02-26 21:50
Kuehn Law Encourages CHRD, AVRO, KAMN, and CTLT Investors to Contact Law Firm(Prnewswire)
2024-02-01 01:25
Kuehn Law Encourages ICVX, CSTR, AVRO, and CALB Investors to Contact Law Firm(Prnewswire)
2024-01-30 21:40
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates TAST, AVRO, CALB(Globenewswire)
2024-01-30 17:42
Avrobios road ends in reverse merger with Tim Springer-backed startup(Yahoo Finance)
2024-01-30 01:52
Avrobio's corporate tremor attracts Tectonic for reverse merger(Fiercebiotech)
2024-01-30 01:38
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates AVRO, CALB, BCAL(Prnewswire)
2024-01-29 19:00
AVROBIO and Tectonic Therapeutic Announce Merger(Businesswire)
2023-11-07 20:40
Is AVROBIO (AVRO) Stock Outpacing Its Medical Peers This Year?(Yahoo Finance)
2023-10-22 21:40
Is AVROBIO (AVRO) Outperforming Other Medical Stocks This Year?(Yahoo Finance)
2023-10-05 21:40
Has AVROBIO (AVRO) Outpaced Other Medical Stocks This Year?(Zacks)
2023-07-12 19:08
AVROBIO (AVRO) to Explore Strategic Options, Stock Rises 46%(Yahoo Finance)
2023-07-11 19:00
AVROBIO to Explore Strategic Alternatives(Yahoo Finance)
2023-06-11 19:00
AVROBIO Completes Sale of Cystinosis Gene Therapy Program for $87.5 Million(Yahoo Finance)
2023-05-21 19:00
AVROBIO Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5 Million(Yahoo Finance)
2023-05-18 02:53
Avrobio Touts Positive Data Gene Therapy Trial For Cystinosis, Showing Treatment Durability Of Up To 36 Months(Yahoo Finance)

Page 1 of 4

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment.